Modern Aspects of Treatment diabetic retinopathy and diabetic macular edema

Abstract

Diabetic retinopathy (DR) and diabetic macular edema (DMO) are the main causes of visual impairment in patients with diabetes. An international multicenter study showed that retinal laser coagulation in the case of DMO reduced the risk of vision loss by 50%, but only 16% of patients could improve vision. The use of Ranibizumab, an inhibitor of vascular endothelial growth factor, opened a new era in the treatment of DMA. Its effectiveness and safety have been proven in a number of international studies.